Hikma Pharmaceuticals
High-quality accessible medicines
- B2B
About Hikma Pharmaceuticals
Manufacturing and supplying over 800 generic, specialty, and branded pharmaceutical products to hospitals, physicians, and pharmacists globally.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- London, United Kingdom
- Founded
- 1978
- Revenue
- $3.3BFY2025, publicly reported
- Website
- hikma.com
Hikma Pharmaceuticals in the news
- Hikma stock heads into the open after a modest gain
Hikma's stock rose 0.7% on September 15, 2026, closing at GBP 19.18 on the London Stock Exchange, outperforming the FTSE 100.
- What Does Hikma Pharmaceuticals' (LSE:HIK) Dividend Mean For UK Holders?
Hikma Pharmaceuticals will pay an interim dividend on September 17, 2026, declared in US dollars, reflecting its strong US market presence in generics and injectables.
- Hikma Pharmaceuticals climbs Friday, outperforms market
Hikma Pharmaceuticals PLC shares gained 2.20% on Friday, outperforming the broader market.
Hikma Pharmaceuticals at a glance
Hikma Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in London, United Kingdom.
Hikma Pharmaceuticals was founded in 1978.
Hikma Pharmaceuticals has 10,000+ employees.
Hikma Pharmaceuticals's revenue is $3.3B (FY2025, publicly reported).
Frequently asked questions about Hikma Pharmaceuticals
What is Hikma Pharmaceuticals's revenue?
Hikma Pharmaceuticals's revenue is $3.3B (FY2025, publicly reported).
How many employees does Hikma Pharmaceuticals have?
Hikma Pharmaceuticals has 10,000+ employees.
Where is Hikma Pharmaceuticals headquartered?
Hikma Pharmaceuticals is headquartered in London, United Kingdom.
Selling to companies like Hikma Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies